| Sanofi-Aventis (Suisse) SA - Adacel-Polio 0.5 ml, suspension injectable en seringue préremplie | | 68110 | | 01 | | Adacel-Polio 0.5 ml | | suspension injectable en seringue préremplie | | J07CA02 | | Diphtheria-Pertussis-Poliomyelitis-Tetanus | | 26.08.2022 | | |
| | Composition | | toxoidum diphtheriae min. 2 U.I., toxoidum tetani min. 20 U.I., toxoidum pertussis 2.5 µg, haemagglutininum filamentosum 5 µg, pertactinum 3 µg, fimbriae types 2 et 3 5 µg, virus poliomyelitis typus 1 inactivatus 29 U., virus poliomyelitis typus 2 inactivatus 7 U., virus poliomyelitis typus 3 inactivatus 26 U., aluminii phosphas corresp. aluminium 0.33 mg, phenoxyethanolum, ethanolum 1.01 mg, polysorbatum 80, aqua ad iniectabile, ad suspensionem pro 0.5 ml corresp. ethanolum 0.3 % V/V, residui: formaldehydum, glutaralum, streptomycinum, neomycinum, polymyxinum B, albuminum seri bovis. | | Packungsbestandteile | | | | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 0.5 ml | 24.00 | 42.50 | B | SL | No | | 002 | 0.5 ml | | | B | | Yes | | 003 | 0.5 ml | | | B | | Yes | | 004 | 10 x 0.5 ml | | | B | | Yes | | 005 | 10 x 5 ml | | | B | | Yes | | 006 | 10 x 0.5 ml | | | B | | No |
|
|
